FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1902611000001103: Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25319301000001113 Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
103885501000001117 Temgesic 400microgram sublingual tablets (Indivior UK Ltd) 50 tablet 5 x 10 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register) true Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Is a Buprenorphine 400microgram sublingual tablets sugar free 50 tablet true Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Is pack of Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) false Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has active ingredient Buprenorphine hydrochloride false Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has active ingredient Opiate agonist-antagonist false Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has active ingredient Substance with opioid receptor partial agonist mechanism of action false Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has active ingredient Buprenorphine false Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has manufactured dose form Conventional release sublingual tablet false Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has AMP Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) true Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has specific active ingredient Buprenorphine hydrochloride true Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Temgesic 400microgram sublingual tablets (Schering-Plough Ltd) 50 tablet Has basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start